Tag
Thyrocare Technologies Limited
3 articles
Thyrocare Seeks Shareholder Approval for Subsidiary Divestment
Thyrocare Technologies seeks shareholder approval via postal ballot for two special resolutions concerning its material subsidiary Nueclear Healthcare.
Resolution 1 proposes purchasing land and buildi
Thyrocare Promoter Docon Sells 9.9% Stake
Promoter Docon Technologies sold 1.58 crore Thyrocare shares representing 9.9% equity via market trades on August 13, 2026.
Post-sale, promoter shareholding reduced from 60.92% to 51.02% of total paid
Thyrocare Promoter Releases Pledge on 17.5M Shares
Docon Technologies, Thyrocare's promoter, released pledge on 1.75 crore equity shares (10.99% stake) held as security for API Holdings' NCDs.
The pledge release on August 11, 2026, reduces Docon's enc